Corfu Headache Clinic — Biomedical Watch V2

Traitements4programmes

Essais2liés

Publications7liées

SourceDBlocale

Traitements

4

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
Cefaly deviceMigraine is included in the top-ten disabling diseases and conditions among the Western populations. Non-invasive neurostimulation (t-SMS), including the Cefaly® device, for the treatment of various types of pain is a relatively new field of interest. The aim of the present study was to explore the clinical experience with Cefaly® in a cohort of migraine patients previously refractory or non-tolerant to topiramate prophylaxis. Patients were followed prospectively after having been diagnosed with episodic or chronic migraine with a previous failure to topiramate treatment and having consented to receive preventive treatment with Cefaly® according to their treating physician's suggestion. A 1-month period of baseline observation was followed by a 3-month period of active treatment with transcutaneous supraorbital nerve stimulation (t-SNS) with Cefaly® as the only preventive treatment.	Migraine	À vérifier	Traitement symptomatique		À vérifier
Onabotulinum toxin ATo assess whether there is a sustained benefit and good safety with repeated onabotulinumtoxinA sessions in chronic migraine over more than three years of treatment. We prospectively enrolled 65 chronic migraine patients, who were classified as responders after three sessions of onabotulinumtoxin A and were eligible to further continue treatment.	Migraine	Phase 4	À vérifier		À vérifier
Onabotulinum toxin ATo assess whether there is a sustained benefit and good safety with repeated onabotulinumtoxinA sessions in chronic migraine over more than three years of treatment. We prospectively enrolled 65 chronic migraine patients, who were classified as responders after three sessions of onabotulinumtoxin A and were eligible to further continue treatment.	Migraine	Phase 4	À vérifier		À vérifier
Cefaly deviceMigraine is included in the top-ten disabling diseases and conditions among the Western populations. Non-invasive neurostimulation (t-SMS), including the Cefaly® device, for the treatment of various types of pain is a relatively new field of interest. The aim of the present study was to explore the clinical experience with Cefaly® in a cohort of migraine patients previously refractory or non-tolerant to topiramate prophylaxis. Patients were followed prospectively after having been diagnosed with episodic or chronic migraine with a previous failure to topiramate treatment and having consented to receive preventive treatment with Cefaly® according to their treating physician's suggestion. A 1-month period of baseline observation was followed by a 3-month period of active treatment with transcutaneous supraorbital nerve stimulation (t-SNS) with Cefaly® as the only preventive treatment.	Migraine	À vérifier	Traitement symptomatique		À vérifier

Essais cliniques

2

Molécule	Indication / population	Phase	NCT	Titre	Statut
Cefaly device	Migraine	À vérifier	NCT03125525	Clinical Experience With Transcutaneous Supraorbital Nerve Stimulation in Refractory Migraine	COMPLETED
Onabotulinum toxin A	Migraine	Phase 4	NCT03606356	Sustained onabotulinumtoxinA Therapeutic Benefits in Patients With Chronic Migraine	COMPLETED

Publications

7

Molécule	Indication / population	Titre	Journal	Date
Cefaly device		[Neurostimulation of the supraorbital nerve with the Cefaly device - a new method for the treatment of migraine].	Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Onabotulinum toxin A		Real-world treatment switching and healthcare costs of onabotulinumtoxinA and calcitonin gene-related peptide monoclonal antibodies in Medicare patients with chronic migraine: a retrospective claims analysis.	Journal of medical economics
Onabotulinum toxin A		EMG-guided Onabotulinum Toxin A for provoked vestibulodynia: addressing methodological concerns while confirming clinical benefit (Reply to Letter-to-the-Editor).	American journal of obstetrics and gynecology
Cefaly device		Peripheral Neuromodulation for the Management of Headache.	Anesthesiology and pain medicine
Cefaly device		Alterations of Resting-State Locus Coeruleus Functional Connectivity After Transdermal Trigeminal Electrical Neuromodulation in Insomnia.	Frontiers in psychiatry
Onabotulinum toxin A		Botulinum toxin in peripheral facial paralysis: systematic review and rehabilitation perspectives.	European journal of physical and rehabilitation medicine
Onabotulinum toxin A		Repeated botulinum toxin injections for neurogenic thoracic outlet syndrome: A case report.	Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology